Posted on February 11, 2025

MSTS 2024

Dr. Michelle Ghert and her research team, Olivia Virag, Hadia Farrukh and Abbey Kunzli, attended the Musculoskeletal Tumor Society’s Annual Meeting last month in Chicago. Dr. Ghert and other investigators presented studies related to the PARITY, SAFETY and PERFORM Trials. While in Chicago, the team also held an Investigator Meeting for the Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) trial on September 11, 2024. This hybrid meeting was attended by 45 investigators including senior methodology experts, Dr. Sheila Sprague from McMaster and Dr. Nathan O'Hara from the University of Maryland. Elements of the PERFORM trial protocol were presented and discussed, and attendees participated in a discrete choice experiment to determine the hierarchy of the composite outcome as part of the trial’s protocol development. Enrollment for the trial is expected to begin in 2025!